Lessons from the Pandemic: Responding to Emerging Zoonotic Viral Diseases

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 1R13AI169793-01

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2022
    2023
  • Known Financial Commitments (USD)

    $11,000
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    Thale Jarvis
  • Research Location

    United States of America
  • Lead Research Institution

    KEYSTONE SYMPOSIA
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Not applicable

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Other

Abstract

ABSTRACT Support is requested for a Keystone Symposia conference entitled Lessons from the Pandemic: Responding to Emerging Zoonotic Viral Diseases, organized by Drs. Linfa Wang, Sarah Catherine Gilbert and William E. Dowling. The conference will be held in Snowbird, Utah from April 10-13, 2022. Seventeen years after the SARS outbreak, the international scientific and non-scientific communities were still not prepared to respond to the COVID-19 pandemic. This conference will focus on the gaps identified from the COVID-19 pandemic and address needs for improved global preparedness to outbreaks. This program will cover topics on new approaches to both the technical and policy aspects of pandemic preparedness. The timing of a conference such as this is ideal and will allow for a very concentrated discussion on certain topics such as the unprecedented surge of scientific focus and government/business investment for COVID-19. Topics will include early warning systems to detect emerging zoonotic threats, rapid development and deployment of diagnostics, model systems, platforms for rapid development of countermeasures including vaccines and therapeutics, and manufacturing challenges for global deployment. It is anticipated that by building a program which focuses on both science and policy areas, that it will help facilitate a paradigm shift by bringing interdisciplinary groups together. Although the main focus for this program will be on coronaviruses, other high profile emerging infectious disease viral pathogens will be included for meaningful comparative analysis. Finally, the program will cover the importance of manufacturing during a global pandemic.